Ncardia
Peter Udall is an experienced professional in business development and sales within the biotechnology and life sciences sectors. Currently serving as Senior Director of Business Development for the Western US at Ncardia since March 2024, Peter Udall previously held the position of Sr. Instrument Sales Specialist at Akoya Biosciences, Inc. from October 2021 to March 2024. Prior roles include Business Development Manager for the Western US at MIMETAS, where Peter Udall contributed to the advancement of innovative 3D microfluidic platforms for drug discovery. Additional experience includes senior roles at Fujifilm Cellular Dynamics and Miltenyi Biotec, spanning technical sales and account management. Peter Udall earned a Bachelor of Science degree from the University of Arizona.
This person is not in any offices
Ncardia
Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications. Explore our website to learn more www.ncardia.com.